Whole brain radiotherapy for non-small cell lung cancer - Authors' reply

Affiliations

¹ Medical Research Council Clinical Trials Unit at University College London, London WC2B 6NH, UK. Electronic address: ruth.langley@ucl.ac.uk.
² Medical Research Council Clinical Trials Unit at University College London, London WC2B 6NH, UK.
³ Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Hull, UK.
⁴ Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK.
⁵ Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Comment

Ruth E Langley et al. Lancet. 2017.

. 2017 Apr 8;389(10077):1395-1396.

doi: 10.1016/S0140-6736(17)30892-9.

¹ Medical Research Council Clinical Trials Unit at University College London, London WC2B 6NH, UK. Electronic address: ruth.langley@ucl.ac.uk.
² Medical Research Council Clinical Trials Unit at University College London, London WC2B 6NH, UK.
³ Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Hull, UK.
⁴ Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK.
⁵ Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

No abstract available

Comment on

Whole brain radiotherapy for non-small cell lung cancer.
Cagney DN, Alexander BM, Aizer AA. Cagney DN, et al. Lancet. 2017 Apr 8;389(10077):1394-1395. doi: 10.1016/S0140-6736(17)30895-4. Lancet. 2017. PMID: 28402816 No abstract available.
Whole brain radiotherapy for non-small cell lung cancer.
Zhu J, Kang M, Fan X. Zhu J, et al. Lancet. 2017 Apr 8;389(10077):1395. doi: 10.1016/S0140-6736(17)30894-2. Lancet. 2017. PMID: 28402817 No abstract available.